See the DrugPatentWatch profile for vascepa

Based on the information available, there may be potential discounts for Vascepa medication. Vascepa, a prescription medication used to lower triglyceride levels, is manufactured by Amarin Pharma Inc. [1]

According to the drug patent watchdog site, DrugPatentWatch.com, Vascepa's patent expired in December 2020 in the United States. [2] This expiration may lead to the availability of generic versions of the medication, potentially reducing its cost. However, it is essential to note that the price reduction may not be immediate, as it typically takes time for generic versions to become available on the market.

Additionally, Amarin Pharma Inc. offers a patient assistance program called Vascepa Together. [3] This program provides Vascepa medication at no cost for eligible, uninsured patients who cannot afford the medication. Eligibility for the program is based on several factors, including income and insurance status.

In conclusion, there may be potential discounts for Vascepa medication due to the expiration of its patent and the availability of patient assistance programs. Patients are encouraged to contact Amarin Pharma Inc. or their healthcare provider for more information on Vascepa discounts and assistance programs.

Sources:

1. Vascepa (Icosapent Ethyl) Capsules, Amarin Pharma Inc. <https://www.amarincorp.com/products/vascepa/>
2. Vascepa (Icosapent Ethyl) Capsules, DrugPatentWatch.com. <https://www.drugpatentwatch.com/drugs/vascepa-icosapent-ethyl/>
3. Vascepa Together, Amarin Pharma Inc. <https://www.vascepatogether.com/>